The seroprevalence data for India, thus far, is extremely problematic (very biased samples). But that was just one example - Algeria is increasing in deaths and cases. Comparing them to France, which is stable, on deaths/mil makes no sense
-
-
This Tweet is unavailable.
-
Answered: - no study is missing, just misclassified - early treatment unlikely to have benefit based on robust evidence - cbf re-reading your references to find the study you mean - any treatment 'may' be effective, this one appears unlikely to be
- Show replies
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
